•
Dec 31, 2018

Corcept Therapeutics Q4 2018 Earnings Report

Total Revenue
$66.8M
Previous year: $53.3M
+25.4%
EPS
$0.24
Previous year: $0.19
+26.3%
Gross Profit
$65.3M
Previous year: $52.1M
+25.2%
Cash and Equivalents
$41.6M
Previous year: $31.1M
+34.0%
Free Cash Flow
$21.4M
Previous year: $24.9M
-13.9%
Total Assets
$312M
Previous year: $221M
+41.3%

Corcept Therapeutics

Corcept Therapeutics